Global use of Haemophilus influenzae type b conjugate vaccine.
Linda R Ojo;
Rosalyn E O'Loughlin;
Adam L Cohen;
Jennifer D Loo;
Karen M Edmond;
Sharmila S Shetty;
Allyson P Bear;
Lois Privor-Dumm;
Ulla K Griffiths;
Rana Hajjeh;
(2010)
Global use of Haemophilus influenzae type b conjugate vaccine.
Vaccine, 28 (43).
pp. 7117-7122.
ISSN 0264-410X
DOI: 10.1016/j.vaccine.2010.07.074
Haemophilus influenzae type b (Hib) conjugate vaccines have been underutilized globally. We report progress in global use of Hib vaccines included in national immunization schedules. The number of countries using Hib vaccine increased from 89/193 (46%) in 2004 to 158/193 (82%) by the end of 2009. The increase was greatest among low-income countries eligible for financial support from the GAVI Alliance [13/75 (17%) in 2004, 60/72 (83%) by the end of 2009], and can be attributed to various factors. Additional efforts are still needed to increase vaccine adoption in lower middle income countries [20/31 (65%) by the end of 2009].
| Item Type | Article |
|---|---|
| Keywords | Haemophilus influenzae type b, Vaccine, Developing countries, DISEASE, CHILDREN, BURDEN, IMMUNIZATION, ELIMINATION, MENINGITIS, PNEUMONIA, ASIA |
| ISI | 283970300022 |